Axovant Sciences Ltd. (AXON) Earnings
|
Expand Research on AXON
| Next EPS Date | 8/4/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +16.3% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +10.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/12/26 |
Q126 | N/A | $1.59 | N/A | N/A | $777.74M | N/A | N/A | N/A | ||
| 2/24/26 | Q425 | $2.15 | $1.60 | +$0.55 | $797M | $755.55M | N/A | ![]() | ![]() | Details | |
| 11/4/25 | Q325 | $1.17 | $1.52 | -$0.35 | $711M | $704.84M | = | ![]() | ![]() | Details | |
| 8/4/25 | Q225 | $2.12 | $1.46 | +$0.66 | $669M | $640.3M | = | ![]() | ![]() | Details | |
| 5/7/25 | Q125 | $1.41 | $1.30 | +$0.11 | $604M | $585.67M | = | ![]() | ![]() | Details | |
| 2/25/25 | Q424 | $2.08 | $1.40 | +$0.68 | $575M | $566.8M | = | ![]() | ![]() | Details | |
| 11/7/24 | Q324 | $1.45 | $1.19 | +$0.26 | $544.27M | $524.47M | = | ![]() | ![]() | Details | |
| 8/6/24 | Q224 | $1.20 | $1.02 | +$0.18 | $504M | $477.85M | = | ![]() | ![]() | Details |



